Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Atypical Femoral Fractures

Back to Topics
Contents
0%

Atypical Femoral Fractures

Comprehensive guide to atypical femoral fractures - bisphosphonate-associated fractures, ASBMR criteria, surgical management, and drug holiday protocols for Orthopaedic orthopaedic exam

complete
Updated: 2024-12-18
High Yield Overview

ATYPICAL FEMORAL FRACTURES - BISPHOSPHONATE-ASSOCIATED

Subtrochanteric/Diaphyseal | Transverse or Short Oblique | Associated with Prolonged Antiresorptive Therapy

5+Years bisphosphonate use increases risk
3-10Per 10,000 patient-years incidence
100xLower than prevented hip fractures
28%Bilateral occurrence rate

ASBMR MAJOR CRITERIA (4 of 5 Required)

Location
PatternSubtrochanteric or diaphyseal (distal to lesser trochanter)
TreatmentRule out peritrochanteric fractures
Fracture Pattern
PatternTransverse or short oblique (less than 30 degrees)
TreatmentDifferent from typical spiral
Minimal/No Trauma
PatternFall from standing height or less
TreatmentLow-energy mechanism
Non-Comminuted
PatternNo or minimal comminution
TreatmentSimple fracture pattern
Lateral Cortex Beaking
PatternLocalized periosteal reaction at fracture site
TreatmentStress fracture origin

Critical Must-Knows

  • ASBMR criteria define atypical fractures - learn the 5 major features
  • Bisphosphonate use greater than 5 years significantly increases risk
  • Check contralateral femur - 28% bilateral, may be prodromal
  • Drug holiday consideration after complete fracture
  • IM nail preferred - allows prophylactic fixation of contralateral

Examiner's Pearls

  • "
    Prodromal thigh pain in 70% - often for weeks/months before fracture
  • "
    Lateral cortex stress reaction is pathognomonic on X-ray
  • "
    Risk-benefit still favors bisphosphonates in most osteoporotic patients
  • "
    Glucocorticoid use and Asian ethnicity increase risk

Clinical Imaging

Imaging Gallery

Multimodality imaging workup of atypical femoral fracture showing X-ray, bone scan, and MRI
Click to expand
Multimodality workup of atypical femoral fracture in a bisphosphonate-treated patient: (a) AP femur X-ray showing the pathognomonic lateral cortex thickening and beaking (arrow) - this localized periosteal reaction at the stress fracture origin is a key ASBMR criterion, (b) Whole-body bone scan demonstrating bilateral femoral uptake (arrows) indicating stress reactions - 28% of patients have bilateral involvement, (c-d) Coronal MRI showing bone marrow edema surrounding the stress fracture site, (e) X-ray with arrow showing the lateral cortex stress reaction. Always image the contralateral femur.Credit: Tins BJ et al., Insights Imaging (PMC4330230) - CC-BY
Bilateral atypical femoral fractures with IM nail treatment
Click to expand
Bilateral atypical femoral fractures demonstrating the 28% bilateral occurrence rate: (a) Right femur showing prodromal lateral cortex thickening before complete fracture, (b) Left femur with similar prodromal changes, (c) Complete transverse subtrochanteric fracture with characteristic short oblique pattern - note minimal comminution (ASBMR criterion), (d) Post-operative view showing intramedullary nail fixation - the preferred treatment as it allows load-sharing and protects the entire femur.Credit: Tonogai I et al., Case Rep Orthop (PMC4129925) - CC-BY

Critical Atypical Femoral Fracture Exam Points

ASBMR Criteria

4 of 5 major criteria must be present for diagnosis. Location (subtrochanteric/diaphyseal), transverse/short oblique pattern, minimal trauma, non-comminuted, lateral cortex beaking. Know these criteria.

Prodromal Symptoms

70% have prodromal thigh pain for weeks to months before complete fracture. This is a missed opportunity for prophylactic treatment. Any patient on bisphosphonates with thigh pain needs imaging.

Check Contralateral

28% have bilateral involvement. Always image the contralateral femur. May be prodromal (incomplete fracture) requiring prophylactic fixation. Same surgery session if complete and prodromal.

IM Nail Preferred

Intramedullary nail is preferred fixation. Allows load-sharing, protects entire femur, enables prophylactic fixation of contralateral. Avoid lateral plate alone (stress riser at plate end).

Atypical Femoral Fracture Management Algorithm

PresentationKey ActionTreatment
Complete atypical fractureConfirm ASBMR criteria, image contralateralIM nail fixation, consider drug holiday
Incomplete fracture (prodromal)Protected weight bearing, serial imagingProphylactic IM nail if progression or persistent pain
Thigh pain on bisphosphonatesX-ray and MRI if X-ray negativeStop bisphosphonate, calcium/vitamin D, monitor
Bilateral involvementStage surgery or fix both at same sessionIM nail both femurs
Post-fracture bone healthDrug holiday vs alternative agentEndocrinology referral, fracture liaison service
Mnemonic

ASBMR - Major Criteria

A
Atraumatic (minimal/no trauma)
Fall from standing height or less
S
Subtrochanteric or shaft
Distal to lesser trochanter to supracondylar flare
B
Beaking of lateral cortex
Periosteal stress reaction
M
Minimal comminution
Non-comminuted or minimal
R
Right angle (transverse/short oblique)
Less than 30 degrees obliquity

Memory Hook:ASBMR = American Society for Bone and Mineral Research - use their initials for criteria

Mnemonic

BISPHOSPHONATE - Risk Factors

B
Bisphosphonate duration greater than 5 years
Most important risk factor
I
Increased age
Older patients at higher risk
S
Steroid use (glucocorticoids)
Independent risk factor
P
Proton pump inhibitors
May increase risk
H
Hip geometry (varus)
Lateral cortex stress concentration
O
Other antiresorptives (denosumab)
Same mechanism
S
South Asian/East Asian ethnicity
Higher incidence
P
Prior fracture contralateral
High risk for bilateral
H
Hypophosphatasia
Rare but important differential
O
Osteoporosis severity
Underlying bone quality
N
Nutritional deficiencies (vitamin D, calcium)
Impaired healing
A
Associated rheumatoid arthritis
Disease and treatment effects
T
Thigh bowing (femoral varus)
Mechanical stress concentration
E
Estrogen receptor status
Hormonal factors

Memory Hook:The drug name reminds you of risk factors - duration is key

Mnemonic

NAIL - Why IM Nail Preferred

N
Neutralizes bending forces
Load-sharing device
A
Allows prophylactic fixation contralateral
Same anesthetic
I
Intramedullary location
Protects entire femur
L
Less stress concentration
No plate end stress riser

Memory Hook:NAIL is the answer for atypical femoral fractures

Mnemonic

THIGH - Prodromal Symptoms

T
Thigh pain (anterior or lateral)
May precede fracture by months
H
History of bisphosphonate use
Duration is key
I
Investigate with imaging
X-ray then MRI
G
Get contralateral films
Check for bilateral
H
High suspicion = prophylactic treatment
Consider fixation

Memory Hook:THIGH pain in bisphosphonate users should raise suspicion

Overview and Epidemiology

Atypical femoral fractures (AFFs) are stress fractures of the femoral shaft associated with prolonged antiresorptive therapy, particularly bisphosphonates. They have distinct clinical and radiographic features.

Historical context:

  • First reports emerged in 2005-2007
  • ASBMR Task Force criteria established 2010, revised 2013
  • Led to "drug holiday" concept for long-term bisphosphonate users

Risk-Benefit Context

Despite concerns about AFFs, bisphosphonates prevent far more fractures than they cause. The incidence of AFF is approximately 3-10 per 10,000 patient-years, while bisphosphonates prevent approximately 300 hip fractures per 10,000 patient-years. The risk-benefit still strongly favors treatment in most osteoporotic patients.

Epidemiology:

  • Incidence: 3-10 per 10,000 patient-years (increases with duration)
  • Female predominance (reflects bisphosphonate use patterns)
  • Mean age 65-75 years
  • Asian ethnicity: higher risk
  • Risk increases exponentially after 5+ years of bisphosphonate use

Risk factors:

  • Duration of bisphosphonate use (most important - risk doubles after 5 years)
  • Glucocorticoid use
  • Asian ethnicity
  • Femoral bowing (varus geometry)
  • Rheumatoid arthritis
  • Prior contralateral AFF
  • Vitamin D deficiency

Anatomy and Pathophysiology

Location of atypical fractures:

AFFs occur in specific locations:

  • Subtrochanteric region: 5cm distal to lesser trochanter
  • Femoral shaft (diaphysis): To supracondylar flare

These locations correlate with areas of maximum tensile stress on the lateral cortex during gait.

Pathophysiology:

How bisphosphonates contribute to AFFs:

  1. Suppressed bone turnover:

    • Bisphosphonates inhibit osteoclast activity
    • Bone remodeling is suppressed
    • Microdamage accumulates without repair
  2. Altered bone quality:

    • Increased mineralization over time
    • More homogeneous bone matrix
    • Reduced ability to absorb energy (more brittle)
  3. Stress fracture progression:

    • Microcracks develop in lateral cortex
    • Unable to heal due to suppressed turnover
    • Progress to complete fracture

The lateral cortex is under maximum tension during weight-bearing, making it vulnerable to stress fracture development.

Why the lateral cortex?

During normal gait, the femur experiences bending moments:

  • Lateral cortex: Under tension (stretching)
  • Medial cortex: Under compression

Tension forces cause the stress fracture to initiate laterally and propagate medially, explaining the characteristic radiographic appearance.

Femoral geometry effects: Varus alignment increases lateral cortex stress, femoral bowing increases bending moment, and Asian patients often have more varus/bowing contributing to higher incidence.

Effects on bone material properties:

PropertyNormal BoneLong-term Bisphosphonate
MineralizationVariableIncreased, homogeneous
Collagen cross-linkingNormalAltered
MicrodamageRepairedAccumulated
Energy absorptionHigherLower (brittle)
Fracture toughnessHigherReduced

Bone Quality Trade-off

Bisphosphonates improve bone density and reduce vertebral/hip fracture risk. However, long-term use may alter bone quality in ways that increase brittleness. This is why drug holidays are considered after 5+ years.

Classification - ASBMR Criteria

ASBMR 2013 Revised Major Criteria

To diagnose an atypical femoral fracture, 4 of 5 major criteria must be present:

CriterionDescriptionKey Points
1. LocationSubtrochanteric or diaphysealDistal to lesser trochanter to supracondylar
2. PatternTransverse or short obliqueLess than 30 degrees from horizontal
3. TraumaMinimal or no traumaFall from standing or less, no trauma
4. ComminutionNon-comminuted or minimalSimple fracture pattern
5. Lateral cortexLocalized periosteal/endosteal reactionCortical thickening, beaking

Lateral Beaking

Lateral cortex beaking is the pathognomonic feature. It represents the stress reaction where the fracture initiates. On X-ray, look for localized cortical thickening with a transverse lucent line.

Lateral cortex beaking in atypical femoral fracture
Click to expand
Two-panel radiograph demonstrating the classic lateral cortex beaking sign (pathognomonic for AFF): (1A) AP femur X-ray with arrow pointing to localized lateral cortical thickening and early stress fracture at the beaking site - this represents the prodromal phase before complete fracture. (1B) Post-operative AP showing intramedullary nail fixation after progression to complete fracture. The beaking sign should prompt consideration for prophylactic fixation.Credit: Bhadada SK et al., Indian J Med Res (PMC4181159) - CC BY 4.0

ASBMR Minor Criteria (not required for diagnosis but supportive):

  • Generalized cortical thickening of the diaphysis
  • Bilateral prodromal symptoms or fractures
  • Delayed fracture healing
  • Comorbid conditions (e.g., vitamin D deficiency, RA, hypophosphatasia)
  • Use of pharmaceutical agents (bisphosphonates, denosumab, glucocorticoids, PPIs)

These criteria support the diagnosis but are not required to meet the definition.

Classification by Completeness:

TypeDefinitionManagement
Incomplete (Prodromal)Lateral cortex involvement onlyProtected WB, consider prophylactic fixation
CompleteThrough both corticesOperative fixation required

Incomplete fractures:

  • Represent early stress fractures
  • May have only cortical beaking visible
  • Often painful (prodromal thigh pain)
  • At risk for progression to complete fracture
  • Consider prophylactic nailing if persistent pain or progression

Complete fractures require operative fixation. Incomplete fractures may be managed conservatively initially but often progress.

Natural history of atypical femoral fracture from incomplete to complete
Click to expand
Five-panel (A-E) radiographic series demonstrating the natural history and treatment of atypical femoral fracture: (A) Incomplete transverse mid-shaft lateral stress fracture - the hallmark of early AFF, (B) Progression to complete transverse fracture through both cortices, (C-D) Intramedullary nail fixation with initial healing, (E) Solid union at follow-up. This series illustrates why incomplete AFFs warrant close monitoring and consideration for prophylactic fixation.Credit: Open-i/NIH (PMC5365307) - CC BY 4.0

Important differentials:

ConditionFeaturesDistinguishing Points
Typical subtrochanteric fractureSpiral/comminuted, high-energyHigh-energy mechanism, no lateral beaking
Pathological fractureLytic lesionTumor visible, destructive lesion
Stress fracture (other)Athletes, militaryNo bisphosphonate history, medial cortex often
HypophosphatasiaLow ALP, pseudofracturesGenetic condition, low alkaline phosphatase

Peritrochanteric Excluded

Peritrochanteric fractures are NOT atypical fractures even in bisphosphonate users. The ASBMR criteria specifically exclude the peritrochanteric region (intertrochanteric and femoral neck).

Clinical Presentation and Assessment

History:

  • Duration and type of bisphosphonate/antiresorptive therapy
  • Prodromal thigh or groin pain (present in 70%)
  • Mechanism of fracture (usually minimal trauma)
  • Previous contralateral symptoms or fracture
  • Osteoporosis treatment history
  • Glucocorticoid use

Prodromal symptoms:

Prodromal Symptoms and Findings

FeatureCharacteristicClinical Significance
Thigh painAnterior or lateral thighMay precede complete fracture by weeks to months
Pain with activityWorse with weight bearingTypical stress fracture behavior
Dull ache at restMay have night painIndicates progressive stress reaction
Bilateral symptoms28% have bilateral involvementAlways image contralateral femur

Physical examination (complete fracture):

  • Shortened, externally rotated limb
  • Thigh swelling and deformity
  • Unable to bear weight
  • Neurovascular examination (usually intact)
  • Skin assessment for open injury

Physical examination (incomplete fracture):

  • May have normal appearance
  • Point tenderness over lateral thigh
  • Pain with weight bearing
  • Full range of hip motion usually preserved

Prodromal Pain

70% of patients with complete AFFs report prodromal thigh pain for weeks to months beforehand. This represents a missed opportunity for intervention. Any patient on long-term bisphosphonates with thigh pain should have imaging to rule out stress fracture.

Investigations

Radiographic assessment:

Plain X-rays (AP and lateral femur):

  • Full-length femur views essential
  • Look for lateral cortex beaking/thickening
  • Transverse fracture line orientation
  • Check for contralateral changes (bilateral imaging mandatory)

Key X-ray findings:

FindingDescriptionSignificance
Lateral beakingLocalized cortical thickeningPathognomonic stress reaction
Transverse lucencyCrack in lateral cortexIncomplete fracture
Complete fractureTransverse pattern, minimal comminutionMeets ASBMR criteria
Medial spikeMedial cortex beak on complete fractureCommon finding

Full-Length Films

Always obtain full-length femur X-rays. This allows assessment of the entire femur for stress reactions and helps plan surgical fixation (nail length, starting point).

Additional imaging:

MRI (if X-ray inconclusive):

  • Bone marrow edema at stress reaction site
  • Fracture line may be visible before X-ray changes
  • Useful for early/incomplete fractures

Bone scan:

  • Hot spot at stress fracture site
  • Less specific than MRI
  • Can assess bilateral involvement

CT scan:

  • Better cortical detail than X-ray
  • Can show early cortical changes
  • Helpful for surgical planning

Laboratory investigations:

  • Vitamin D level (deficiency common, affects healing)
  • Calcium, phosphate
  • Alkaline phosphatase (low in hypophosphatasia)
  • PTH if secondary hyperparathyroidism suspected
  • Bone turnover markers (research interest)

Management

📊 Management Algorithm
Atypical femoral fractures management algorithm flowchart
Click to expand
Treatment decision algorithm - from ASBMR criteria to IM nailing vs prophylactic fixationCredit: OrthoVellum

Surgical fixation is required for all complete AFFs.

Preferred fixation: Intramedullary nail

  • Cephalomedullary nail (e.g., gamma nail, PFNA)
  • Provides load-sharing fixation
  • Protects entire femur
  • Allows immediate weight bearing (depending on fixation)
  • Enables bilateral fixation at same sitting

Surgical considerations:

  • Entry point: piriformis or trochanteric entry based on nail design
  • Ensure good distal locking
  • Consider supplementary fixation if comminuted
  • Assess and address contralateral femur

Avoid Lateral Plate Alone

Lateral plate fixation alone should be avoided for atypical fractures. The plate creates a stress riser at its ends, and the abnormal bone quality may predispose to failure. IM nail is preferred. If plate is used, protect entire femur.

Management of prodromal/incomplete fractures:

Initial conservative approach:

  • Protected weight bearing (crutches, walker)
  • Bisphosphonate cessation
  • Calcium and vitamin D supplementation
  • Serial imaging (X-ray every 4-6 weeks)
  • Activity modification

Indications for prophylactic fixation:

  • Progression of fracture line on serial imaging
  • Persistent pain despite conservative measures
  • Greater than 50% cortical involvement
  • Patient preference to reduce fracture risk
  • Non-compliant with protected weight bearing

Prophylactic IM nailing:

  • Same technique as complete fracture
  • Reduces risk of complete fracture
  • Allows immediate weight bearing
  • Should be strongly considered if contralateral complete fracture

The decision for prophylactic fixation balances surgical risk against fracture risk. Most surgeons have a low threshold for prophylactic nailing given the morbidity of complete fracture.

Bilateral involvement occurs in 28%:

Assessment:

  • Always image contralateral femur
  • Full-length X-rays
  • MRI if symptomatic with normal X-rays

Management of contralateral findings:

FindingManagement
NormalSurveillance, cessation of bisphosphonate
Cortical thickening onlyConservative, close follow-up
Incomplete fracture lineStrong consideration for prophylactic nail
Complete fractureSurgical fixation

Staged vs same-session surgery: If complete fracture on one side and incomplete on other, consider fixing both at same surgery. This reduces second anesthetic and total recovery time. Discuss with patient preoperatively.

Drug holiday considerations:

After AFF, decisions about ongoing osteoporosis treatment are complex:

  • Bisphosphonate cessation recommended (drug holiday)
  • Duration of holiday variable (1-2 years typical)
  • Balance fracture prevention vs AFF risk
  • Endocrinology/bone specialist referral recommended

Alternative treatments:

AgentConsiderationNotes
Teriparatide (PTH analog)May aid healingAnabolic, 2-year limit
DenosumabSimilar mechanism to BPMay also cause AFF, no holiday benefit
RomosozumabNewer anabolicLimited data on AFF risk
Calcium/Vitamin DEssential adjunctOptimize levels

Teriparatide for Healing

Teriparatide (recombinant PTH) is an anabolic agent that stimulates bone formation. Some evidence suggests it may aid healing of atypical fractures. Consider referral to endocrinology for discussion of post-fracture treatment.

Surgical Technique

Periprosthetic atypical femoral fracture with combined IM nail and lateral plate fixation
Click to expand
Periprosthetic atypical femoral fracture complicating prior IM nail: (A) AP radiograph showing transverse fracture at the lateral plate tip with characteristic lateral cortex involvement - note the fracture propagates medially from the lateral cortex stress riser, (B) Fracture clearly visible with lateral cortex beaking (arrow), (C) Full-length view showing combined fixation construct. Periprosthetic AFF requires careful planning for revision fixation.Credit: PMC4972725 - CC-BY
Atypical femoral fracture at femoral stem tip
Click to expand
Atypical femoral fracture occurring at the tip of a cemented femoral stem: (Left) AP radiograph demonstrating the transverse fracture pattern with localized periosteal thickening at the lateral cortex (black arrow) and medial spike (white arrow), (Right) Similar view confirming ASBMR major criteria features. Prosthetic stem tips create stress risers that can predispose to atypical fracture pattern in patients on antiresorptive therapy.Credit: Niikura T et al., J Med Case Rep (PMC4427957) - CC-BY

Patient positioning:

  • Supine on fracture table (radiolucent)
  • Boot attached with traction
  • Contralateral leg in lithotomy or extended
  • C-arm access for AP and lateral views

Reduction:

  • Traction and internal rotation typically reduces
  • May need external reduction aids if shortening/rotation
  • Varus tendency common - ensure proper alignment
  • Confirm reduction on fluoroscopy before nailing

Key reduction considerations:

  • Atypical fractures often have sharp transverse edges
  • May need to open and reduce if closed reduction fails
  • Avoid excessive manipulation (bone quality poor)

Proper positioning and reduction are essential before proceeding with nailing.

Entry point:

  • Piriformis or trochanteric entry (depends on nail design)
  • Standard landmarks apply
  • Verify with fluoroscopy

Reaming:

  • Ream to 1.5-2mm larger than nail diameter
  • Be cautious - bone may be brittle
  • Consider under-reaming slightly in very brittle bone

Nail selection:

  • Long cephalomedullary nail
  • Must span entire femur
  • Lag screw or blade for proximal fixation
  • Multiple distal interlocking screws

Insertion tips: Advance slowly to avoid propagation, watch for cortical perforation (lateral bowing), and confirm position with orthogonal fluoroscopy.

Lag screw or blade placement:

  • Standard technique for chosen implant
  • Central-central or slight inferior placement
  • Tip-apex distance less than 25mm
  • Confirm on AP and lateral

Antirotation screw (if applicable):

  • Follow implant-specific technique
  • Important for rotational stability

Proximal fixation follows standard cephalomedullary nail principles. The atypical fracture location is usually below the proximal screws.

Distal interlocking screws:

  • At least 2 screws (static locking preferred)
  • Use targeting device or freehand technique
  • Avoid prominent hardware

Considerations:

  • Long nail - ensure screws in good bone
  • Avoid anterior cortex perforation
  • May add third screw if bone quality concern

Final steps: Confirm alignment on AP and lateral imaging, check rotation clinically, and assess stability with stress maneuvers before wound closure.

Technique for incomplete fracture:

Same technique as complete fracture with some modifications:

  • No reduction needed (bone is intact)
  • Entry point and reaming as usual
  • Consider smaller diameter nail (less reaming)
  • Full-length nail to protect entire femur

Bilateral fixation at same session:

  • Start with complete fracture side
  • Then prophylactically fix contralateral
  • Consider staged if prolonged surgery/blood loss
  • Discuss with anesthesia preoperatively

Prophylactic nailing is effective in preventing complete fracture and allows immediate weight bearing.

Complications

Complications of Atypical Femoral Fractures

ComplicationIncidencePrevention/Management
Delayed union/nonunion20-30%Teriparatide, revision surgery, bone graft
Contralateral fracture28% overallProphylactic fixation, imaging surveillance
Refracture5-10%Long nail, protect entire femur
Implant failureVariableAdequate fixation, consider bone quality
Thigh pain (persistent)CommonMay relate to implant, bone healing, or new stress reaction
MalalignmentVariableCareful intraoperative assessment, long nail

Delayed union and nonunion:

  • Higher rate than typical femoral fractures (20-30%)
  • Related to suppressed bone turnover
  • Consider teriparatide to stimulate healing
  • May need revision with bone grafting
  • Endocrinology involvement for optimization

Contralateral fracture:

  • 28% have bilateral involvement
  • May present simultaneously or sequentially
  • Emphasizes need for contralateral imaging
  • Prophylactic fixation if incomplete fracture identified

Healing Challenges

AFFs have higher rates of delayed union and nonunion (20-30%) compared to typical femoral shaft fractures. This is due to the underlying suppressed bone turnover from bisphosphonate use. Teriparatide may help stimulate healing.

Postoperative Care and Rehabilitation

Postoperative protocol:

Day 0-14
  • Weight bearing as tolerated (typically)
  • DVT prophylaxis
  • Pain management
  • Early mobilization with physiotherapy
  • Wound care
Week 2-6
  • Progressive ambulation
  • Discharge home when safe
  • Outpatient physiotherapy
  • Monitor wound healing
  • X-ray at 6 weeks
Week 6-12
  • Continued strengthening
  • Serial X-rays to monitor healing
  • Watch for delayed union
  • May require extended time to unite
  • Consider teriparatide if delayed
Month 3-12
  • Ongoing healing assessment
  • May take 6-12 months to fully unite
  • Address bone health
  • Endocrinology referral for osteoporosis management
  • Drug holiday discussion

Key rehabilitation principles:

  • Early weight bearing with IM nail
  • Balance mobility with healing monitoring
  • Extended healing time expected
  • Address falls risk
  • Comprehensive bone health management

Bone health management:

  • Stop bisphosphonate (drug holiday)
  • Calcium 1000-1200mg/day
  • Vitamin D to normalize levels (target greater than 50nmol/L)
  • Refer to endocrinology/bone specialist
  • Consider teriparatide if delayed union
  • Fracture liaison service involvement

Outcomes and Prognosis

Healing outcomes:

FactorImpact on Outcome
Bisphosphonate durationLonger duration associated with slower healing
Nail vs plateNail has better outcomes, fewer complications
Teriparatide useMay accelerate healing
Vitamin D statusDeficiency delays healing
SmokingDelays healing
Contralateral fractureIncreases morbidity

Functional outcomes:

  • Most patients return to pre-injury function
  • Some persistent thigh discomfort common
  • Hardware removal rarely needed
  • Falls prevention important to prevent contralateral fracture

Long-term Considerations

After AFF, patients require ongoing bone health management. This includes drug holiday from bisphosphonates, consideration of alternative treatments (teriparatide), optimization of calcium/vitamin D, and surveillance for contralateral involvement. Fracture liaison service involvement is recommended.

Evidence Base

Expert Consensus
📚 ASBMR Task Force Report 2013
Key Findings:
  • Revised definition of atypical femoral fractures with 5 major and 6 minor criteria. Established that 4 of 5 major criteria required for diagnosis. Confirmed association with bisphosphonate use but noted overall benefit still favors treatment.
Clinical Implication: ASBMR criteria are the standard definition for atypical femoral fractures. Know the 5 major criteria for the exam.
Source: J Bone Miner Res 2014

Level III
📚 Dell et al. Kaiser Permanente Cohort
Key Findings:
  • Incidence of AFF increases with bisphosphonate duration. Risk was 1.78/100,000/year with 2 years use, increasing to 113.1/100,000/year with greater than 8 years use. Risk decreases rapidly after discontinuation.
Clinical Implication: Duration of bisphosphonate use is the key risk factor. Consider drug holiday after 5+ years in low-risk patients.
Source: J Bone Miner Res 2012

Level III
📚 Schilcher et al. Swedish National Register
Key Findings:
  • Bisphosphonate use associated with 46-fold increase in AFF risk. However, authors calculated that for every AFF caused, approximately 100 hip fractures are prevented by treatment.
Clinical Implication: Risk-benefit analysis still strongly favors bisphosphonate treatment in osteoporotic patients. AFFs are rare despite relative risk increase.
Source: N Engl J Med 2011

Level IV
📚 Egol et al. Surgical Outcomes
Key Findings:
  • Intramedullary nailing had better outcomes than lateral plate fixation for atypical fractures. IM nail associated with fewer complications and lower revision rates.
Clinical Implication: IM nail is the preferred fixation for atypical femoral fractures. Avoid lateral plate fixation alone.
Source: J Orthop Trauma 2014

Expert Consensus
📚 Shane et al. Drug Holiday Recommendations
Key Findings:
  • Recommended drug holiday after 5 years for low-risk patients, 10 years for high-risk. Duration of holiday should be individualized. Resume treatment if significant bone loss or new fracture.
Clinical Implication: Drug holidays are reasonable after long-term bisphosphonate use but must be individualized. Involve bone specialists in decision-making.
Source: J Clin Endocrinol Metab 2017

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

Scenario 1: Classic Atypical Femoral Fracture

EXAMINER

"A 72-year-old woman on alendronate for 8 years presents after a fall from standing. X-rays show a transverse subtrochanteric fracture with minimal comminution and lateral cortex thickening. What is your diagnosis and management?"

EXCEPTIONAL ANSWER
This presentation is consistent with an **atypical femoral fracture**. She meets multiple ASBMR major criteria: subtrochanteric location, transverse pattern, minimal trauma, non-comminuted, and lateral cortex beaking. Combined with 8 years of bisphosphonate use, this is a classic presentation. **Immediate management:** - Analgesia, IV access, bloods (including vitamin D) - Splint for comfort - NPO for surgery **Key investigation:** I would obtain **full-length X-rays of both femurs**. Up to 28% of patients have bilateral involvement, and the contralateral side may have a prodromal incomplete fracture requiring prophylactic fixation. **Surgical management:** I would fix this with an **intramedullary cephalomedullary nail**. This is preferred over lateral plate because it is load-sharing, protects the entire femur, and allows prophylactic fixation of the contralateral femur if needed. **Contralateral femur:** If there is an incomplete fracture line or significant cortical changes on the contralateral side, I would discuss prophylactic nailing at the same surgery to prevent a second complete fracture. **Post-fracture bone health:** - Stop bisphosphonate (drug holiday) - Optimize calcium and vitamin D - Referral to endocrinology for ongoing osteoporosis management - Consider teriparatide if delayed healing The key message is recognizing this as an atypical fracture based on ASBMR criteria, checking the contralateral femur, and using IM nail fixation.
KEY POINTS TO SCORE
This meets ASBMR criteria for atypical femoral fracture
8 years bisphosphonate use is key risk factor (greater than 5 years)
Always image contralateral femur (28% bilateral)
IM nail is preferred fixation (load-sharing, protects whole femur)
Consider prophylactic fixation of contralateral if incomplete fracture
Stop bisphosphonate after fracture (drug holiday)
Optimize calcium and vitamin D
Refer to endocrinology for ongoing management
Consider teriparatide if delayed union
Expect slower healing than typical femoral fractures
COMMON TRAPS
✗Missing the atypical features and treating as routine fracture
✗Not imaging contralateral femur
✗Using lateral plate instead of IM nail
✗Not stopping bisphosphonate
✗Not addressing bone health
LIKELY FOLLOW-UPS
"The contralateral femur shows lateral cortex thickening with a faint transverse line but no complete fracture. What do you do?"
"What are the ASBMR major criteria?"
VIVA SCENARIOChallenging

Scenario 2: Prodromal Thigh Pain

EXAMINER

"A 68-year-old woman on denosumab for 4 years presents with 3 months of left thigh pain. X-rays show localized lateral cortex thickening in the subtrochanteric region with a faint transverse lucency. She can walk with a limp. What is your management?"

EXCEPTIONAL ANSWER
This is an **incomplete atypical femoral fracture** (prodromal stage). The lateral cortex thickening with transverse lucency is pathognomonic. Although she is on denosumab rather than bisphosphonate, denosumab has similar effects on bone turnover and is also associated with atypical fractures. **Assessment:** - Confirm findings with MRI if any diagnostic uncertainty - Full-length bilateral femur X-rays to assess both sides - Check vitamin D level - Assess fracture risk (progression likely if untreated) **Management options:** **Option 1: Conservative initially** - Protected weight bearing (crutches/walker) - Stop denosumab - Calcium and vitamin D optimization - Serial X-rays every 4-6 weeks - Low threshold for surgery if progression **Option 2: Prophylactic IM nailing (preferred)** Given: - Visible fracture line (greater than just cortical thickening) - 3 months of symptoms without resolution - Risk of completing to displaced fracture I would strongly recommend **prophylactic IM nailing**. This: - Prevents complete displaced fracture - Allows immediate weight bearing - Relieves symptoms - Avoids the morbidity of complete fracture **Drug management:** - Stop denosumab (but counsel about rebound bone loss) - Consider transition to another agent after consultation with endocrinology - Do not simply stop antiresorptive without plan (rebound risk with denosumab) The key is recognizing this as a high-risk incomplete fracture that warrants prophylactic stabilization.
KEY POINTS TO SCORE
This is an incomplete atypical femoral fracture
Denosumab also associated with AFFs (same mechanism as bisphosphonates)
Prodromal symptoms present for 3 months indicates high progression risk
Visible fracture line on X-ray increases risk of complete fracture
Prophylactic IM nailing is strongly recommended
Stop antiresorptive but be aware of rebound with denosumab
Image contralateral femur
Endocrinology referral for drug management
Cannot simply stop denosumab without transition plan
Protected weight bearing if conservative chosen (but high risk)
COMMON TRAPS
✗Dismissing prodromal symptoms as muscle strain
✗Continuing denosumab
✗Waiting for complete fracture before intervention
✗Stopping denosumab abruptly without transition plan
✗Not imaging contralateral
LIKELY FOLLOW-UPS
"What is the concern with stopping denosumab abruptly?"
"If you choose conservative management, what would make you operate?"
VIVA SCENARIOCritical

Scenario 3: Nonunion of Atypical Fracture

EXAMINER

"A patient had IM nailing of an atypical femoral fracture 9 months ago. She has persistent thigh pain. X-rays show no callus bridging and a persistent fracture line. What is your approach?"

EXCEPTIONAL ANSWER
This is a **nonunion of an atypical femoral fracture**. The lack of callus bridging at 9 months is concerning but not unexpected, as atypical fractures have higher rates of delayed union and nonunion (20-30%) due to the underlying suppressed bone turnover. **Assessment:** - Confirm nonunion on imaging (CT if unclear on X-ray) - Assess implant position and integrity - Check vitamin D, calcium, PTH levels - Smoking status - Consider bone turnover markers - Rule out infection (unlikely but consider) **Medical optimization:** - Ensure bisphosphonate/denosumab remains stopped - Optimize vitamin D (target greater than 75nmol/L) - **Teriparatide (PTH analog)**: Consider starting to stimulate bone formation. Evidence suggests it may aid healing of AFFs. - Smoking cessation if applicable **Surgical options:** **Option 1: Exchange nailing with bone graft** - Remove existing nail - Ream up - Insert larger diameter nail - Add bone graft (autograft from iliac crest or RIA) - Consider plate augmentation **Option 2: Nail retention with augmentation** - If nail is well-positioned - Add lateral plate with bone graft - Diamond configuration **Option 3: Plate fixation with bone graft** - If nail is problematic - Lateral locking plate - Extensive bone grafting - Consider BMP-2 (off-label) The key is combining revision fixation with bone grafting and medical optimization (teriparatide).
KEY POINTS TO SCORE
Nonunion is common with AFFs (20-30%)
Due to underlying suppressed bone turnover
Confirm nonunion on imaging (CT helpful)
Rule out infection
Optimize vitamin D and calcium
Teriparatide may help stimulate healing
Stop smoking if applicable
Revision surgery required: exchange nail or plate with bone graft
Bone graft is essential
Multidisciplinary approach with endocrinology
COMMON TRAPS
✗Waiting too long for union that won't occur
✗Not considering medical optimization (teriparatide)
✗Revision surgery without bone graft
✗Missing vitamin D deficiency
✗Not involving endocrinology
LIKELY FOLLOW-UPS
"What is the mechanism of action of teriparatide?"
"Would you use BMP-2 in this situation?"

MCQ Practice Points

Definition Question

Q: How many of the ASBMR major criteria must be present to diagnose an atypical femoral fracture? A: 4 of 5 major criteria must be present: subtrochanteric/diaphyseal location, transverse or short oblique pattern, minimal/no trauma, non-comminuted or minimal comminution, lateral cortex beaking.

Risk Factor Question

Q: What is the most important risk factor for atypical femoral fractures? A: Duration of bisphosphonate use. Risk increases exponentially after 5 years of use, with risk doubling approximately every 2 years of continued use.

Clinical Question

Q: What percentage of patients have prodromal symptoms before a complete atypical femoral fracture? A: 70% of patients report thigh or groin pain for weeks to months before the complete fracture. This represents an opportunity for early detection and prophylactic treatment.

Fixation Question

Q: What is the preferred fixation for atypical femoral fractures and why? A: Intramedullary nail is preferred because it is load-sharing (protects abnormal bone), protects the entire femur, and allows prophylactic fixation of the contralateral femur. Lateral plate alone is associated with higher failure rates.

Bilateral Question

Q: What percentage of patients with atypical femoral fracture have bilateral involvement? A: 28% have bilateral involvement. This is why imaging of the contralateral femur is mandatory, and prophylactic fixation should be considered if incomplete fracture is identified.

Australian Context

Epidemiology in Australia:

  • Bisphosphonates widely prescribed via PBS
  • Atypical fractures are rare but increasing recognition
  • Asian population (higher proportion in Australia) may have increased risk
  • Fracture liaison services increasingly available

PBS considerations:

  • Bisphosphonates available on PBS for osteoporosis
  • Denosumab available on PBS
  • Teriparatide available on PBS for high fracture risk/nonunion

Clinical practice:

  • Australian guidelines recommend drug holiday consideration after 5 years
  • Endocrinology involvement for complex decisions
  • Fracture liaison services for secondary prevention

Exam Context

In the Orthopaedic exam, be prepared to discuss the ASBMR criteria (know all 5 major criteria), the importance of imaging the contralateral femur, and the rationale for IM nail fixation. Also understand drug holiday concepts and the role of teriparatide in delayed healing.

ATYPICAL FEMORAL FRACTURES

High-Yield Exam Summary

ASBMR MAJOR CRITERIA (4 of 5 Required)

  • •1. Location: Subtrochanteric or femoral shaft
  • •2. Pattern: Transverse or short oblique (less than 30 degrees)
  • •3. Trauma: Minimal or no trauma
  • •4. Comminution: Non-comminuted or minimal
  • •5. Lateral cortex: Localized periosteal/endosteal reaction (beaking)

KEY RISK FACTORS

  • •Bisphosphonate duration greater than 5 years (most important)
  • •Glucocorticoid use
  • •Asian ethnicity
  • •Femoral varus/bowing
  • •Prior contralateral AFF

SURGICAL MANAGEMENT

  • •IM nail preferred (load-sharing, protects whole femur)
  • •Avoid lateral plate alone (stress riser)
  • •Always image contralateral (28% bilateral)
  • •Prophylactic nail if incomplete fracture
  • •Consider bilateral fixation at same sitting

POST-FRACTURE BONE HEALTH

  • •Stop bisphosphonate (drug holiday)
  • •Optimize vitamin D (target greater than 50nmol/L)
  • •Calcium supplementation
  • •Consider teriparatide if delayed union
  • •Endocrinology referral

COMPLICATIONS

  • •Delayed union/nonunion (20-30%)
  • •Contralateral fracture (28%)
  • •Refracture
  • •Prolonged healing time

TRAPS AND PEARLS

  • •70% have prodromal thigh pain - investigate!
  • •Risk-benefit still favors bisphosphonates overall
  • •Lateral beaking is pathognomonic
  • •Peritrochanteric fractures are NOT atypical
  • •Expect longer healing than typical fractures
Quick Stats
Reading Time104 min
Related Topics

Acetabular Fractures

Acromioclavicular Joint Injuries

Acute Compartment Syndrome

Ankle Fractures